Evidence Series Immunoanalysers
Evidence Series Immunoanalysers
![Evidence banner - Purple](https://www.randox.com/wp-content/uploads/2019/06/Evidence-banner-Purple-scaled.jpg)
Powered by Biochip Array Technology
In 2002, Randox invented a world first, Biochip Array Technology (BAT), instantly changing the landscape of diagnostic testing forever. BAT is a multi-analyte platform which provides an unrivaled increase in patient information per sample. Instead of a patient sample needing to be subdivided for each test result, or in some cases re-collected, Biochip Array Technology offers a diagnostic patient profile with each patient sample. So now the patient’s needs become the focus, as BAT delivers the multiple results needed for improved diagnosis.
With over £250 million invested into Biochip Array Technology research and development, Randox have launched a range of Biochip Array Technology immunoanalysers – The Evidence Series. This includes the Evidence, the Evidence Investigator and the Evidence MultiSTAT. Each analyser is developed with boundary pushing engineering, designed to make financial, labour and time savings for the end user. Utilising this technology, the Evidence series guarantees cost-effective, highly accurate and flexible testing solutions.
Why choose the Evidence Series?
Biochip Array Technology Test Menu
Adhesion Molecules
E-Selectin | P-Selectin | L-Selectin | |
Intercellular Adhesion Molecule-I – ICAM-I | Vascular Cell Adhesion Molecule-I –VCAM-I | ||
Alzheimer’s
Apolipoprotein E4 –ApoE4 | Pan Apolipoprotein E – Apo E |
Anaemia
Ferritin | Folate | Vitamin B12 |
Bone Disease
Vitamin D | |||
Cancer
Carcinoembryonic Antigen – CEA | Free Prostate Specific Antigen − FPSA | Total Prostate Specific Antigen − TPSA | |
Cardiac
Cardiac Troponin I – cTnl | Creatine Kinase MB – CKMB | Heart Fatty Acid Binding Protein – H-FABP | Myoglobin |
Cerebral
Brain-Derived Neurotrophic Factor − BDNF | Neuron Specific Enolase − NSE | ||
Cytokines
Epidermal Growth Factor − EGF | Granulocyte Macrophage Colony Stimulating Factor | Interferon-γ − IFN-γ | Interleukin-1 alpha − IL-1α |
Interleukin-1 beta − IL-1β | Interleukin-2 − IL-2 | Interleukin-3 − IL-3 | Interleukin-4 − IL-4 |
Interleukin-5 − IL 5 | Interleukin-6 − IL-6 | Interleukin-7 − IL-7 | Interleukin-8 − IL-8 |
Interleukin-4 − IL-4 | Interleukin-5 − IL 5 | Interleukin-6 − IL-6 | Interleukin-7 − IL-7 |
Interleukin-8 − IL-8 | Interleukin-10 − IL-10 | Interleukin-12p70 − IL-12p70 | Interleukin-13 − IL-13 |
Interleukin-15 − IL 15 | Interleukin-23 − IL-23 | Macrophage Infl ammatory Protein-1α − MIP-1α | Matrix Metalloproteinase 9 − MMP 9 |
Monocyte Chemotactic Protein-1 − MCP-1 | Soluble IL-2 Receptor Alpha − sIL-2Rα | Soluble IL-6 Receptor − sIL-6R | Soluble Tumour Necrosis Factor Receptor 1 − sTNFR1 |
Soluble Tumour Necrosis Factor Receptor 2 − sTNFR2 | Tumour Necrosis Factor-α − TNF-α | Vascular Endothelial Growth Factor − VEGF | |
Diabetes
Insulin | |||
Endocrine
Cortisol | Dehydroepiandrosterone-Sulphate- DHEAS | ||
Fertility / Pregnancy
Estradiol | Follicle Stimulating Hormone − FSH | Luteinizing Hormone − LH | Progesterone |
Prolactin | Sex Hormone Binding Globulin − SHBG | Testosterone | |
Fibrinolysis
D-Dimer |
Gastro
Gastrin 17 – GI7 | Helicobacter pylori – H. pylori | Pepsinogen I – PGI | Pepsinogen II – PGII |
Metabolic
Adiponectin | Ferritin | Insulin | Leptin |
Plasminogen Activator Inhibitor − PAI-1 | Resistin |
Renal
Adiponectin | Complement C3a des Arginine – C3a des Arg | CRP (C-Reactive Protein) | Cystatin C |
D-Dimer | Epidermal Growth Factor − EGF | Fatty Acid Binding Protein-1 − FABP1 | Interleukin-8 − IL-8 |
Macrophage Infl ammatory Protein-1α − MIP-1α | Neutrophil Gelatinase – Associated Lipocalin – NGAL | Soluble Tumour Necrosis Factor Receptor 1 − sTNFR1 | Soluble Tumour Necrosis Factor Receptor 2 − sTNFR2 |
Stroke
Brain-Derived Neurotrophic Factor − BDNF | D-Dimer | Glial Fibrillary Acidic Protein − GFAP | Glutathione S – Transferase Pi – GSTPi |
Heart Fatty Acid Binding Protein – H-FABP | Interleukin-6 − IL-6 | Nucleoside Diphosphate Kinase – NDKA | Neuron Specifi c Enolase − NSE |
Parkinson Protein 7 − PARK-7 | Soluble Tumour Necrosis Factor Receptor 1 − sTNFR1 | ||
Thyroid
Anti-Thyroglobulin − Anti-Tg | Anti-Thyroid Peroxidase − Anti-TPO | Free Tri-iodothyronine − FT3 | Free Thyroxine − FT4 |
Thyroid Stimulating Hormone − TSH | Thyroxine Binding Globulin − TBG | Total Tri-iodothyronine − TT3 | Total Thyroxine − TT4 |
Toxicology
Amphetamine | Barbiturates | Benzodiazepines I | Benzodiazepines II |
Buprenorphine | Cannabinoids – THC | Cocaine Metabolite | Dextromethorphan |
Fentanyl | Ketamine | Meprobamate | Methadone |
Opiate | Oxycodone I | Oxycodone II | Phencyclidine – PCP |
Tramadol | Tricyclic Antidepressants | Zolpidem | |
Molecular
20 SNPs | Adenovirus A/B/C/D/E | APOB – 1 mutation | Bordetella pertussis |
BRAF – 1 mutation | Chlamydia trachomatis – (CT) | Chlamydophila pneumoniae | Coronavirus 229E/NL63 |
Coronavirus OC43/HKU1 | Enterovirus A/B/C | Haemophilus ducreyi – (HD) | Haemophilus influenzae |
Herpes simplex Virus 1– (HSV-1) | Herpes simplex Virus 2 – (HSV-2) | Human Bocavirus 1/2/3 | Human Metapneumovirus – hMPV |
Influenza A/B | KRAS – 16 mutations | LDLR – 38 mutations | Legionella pneumophila |
Moraxella catarrhalis | Mycoplasma genitalium – (MG) | Mycoplasma hominis – (MH) | Mycoplasma pneumoniae |
Neisseria gonorrhoea – (NG) | Parainfluenza Virus 1/2/3/4 | PCSK9 – 1 mutation | PIK3CA – 3 mutations |
Respiratory Syncytial Virus a – RSVa | Respiratory Syncytial Virus b – RSVb | Rhinovirus A/B | Streptococcus pneumoniae |
Treponema pallidum – (TP) | Trichomonas vaginalis – (TV) | Ureaplasma urealyticum – (UU) | |
Veterinary Residues / Food Diagnostics
17β-Clostebol | 5-hydroxy Flunixin | Aflatoxin B1 | Aflatoxin G1/G2 |
Aflatoxin M1 | AHD | Amikacin/Kanamycin | Amino Benzimidazoles |
Amoxicillin | AMOZ | Amphenicols | Ampicillin |
AOZ | Apramycin | Avermectins | Bacitracin |
Baquiloprim | Benzimidazoles | Beta-agonists | Beta-Lactams |
Boldenone | Cefapirin | Cefoperazone | Cefquinome |
Ceftiofur | Cefuroxime | Cephalexin | Cephalonium |
Chloramphenicol | Chlormadinone | Clopidol | Cloxacillin |
Corticosteroids | Dapsone | Decoquinate | Deoxynivalenol |
Dexamethasone | Diacetoxyscirpenol | Diclazuril | Dicloxacillin |
Dihydrostreptomycin | Ergot Alkaloids | Erythromycin | Ethinylestradiol |
Fumonisins | Gentamicin | Gestagens | Halofugine |
Hygromycin B | Imidocarb | Kanamycin | Lasalocid |
Levamisole | Lincomycin | Lincosamides | MaduramicinG |
Melamine | Meloxicam | Metamizole | Methyltestosterone |
Monensin | Moxidectin (MXD) | Nandrolone | Neomycin/Paromomycin |
Nicarbazin | Nitroimidazoles | Nitroxynil | Novobiocin |
Ochratoxin A | Oxacillin | Paxilline | Penicillin G |
Penicillin V | Phenylbutazone | Pirlimycin | Polymixins |
Quinolones | Ractopamine | Rifaximin | Robenidine |
Salinomycin | SEM | Spectinomycin | Spiramycin |
Spiramycin/Josamycin | Stanozolol | Stilbenes | Streptomycin |
Sulfaguanidine | Sulfamethazine | Sulphachlorpyridazine | Sulphadiazine |
Sulphadimethoxine | Sulphadoxine | Sulphamerazine | Sulphamethazine |
Sulphamethizole | Sulphamethoxazole | Sulphamethoxypyridazine | Sulphapyridine |
Sulphaquinoxaline | Sulphathiazole | Sulphisoxazole | Sulphonamides |
T2 toxin | Tetracyclines | Thiabendazole | Thiamphenicol |
Tobramycin | Tolfenamic Acid | Toltrazuril | Trenbolone |
Triclabendazole | Trimethoprim | Tylosin | Tylosin B/Tilmicosin |
Virginiamycin | Virginiamycin M1 | Zearalenone | Zeranol |
Evidence Series Enquiry
Enquire to find out more about our Biochip powered Evidence Series immunoanalysers
Evidence MultiSTAT – Biochip Immunoanalyser
Fast. Fully Automated. Versatile.
![Evidence MultiSTATweb banner](https://www.randox.com/wp-content/uploads/2019/06/Evidence-MultiSTATweb-banner-scaled.jpg)
The Evidence MultiSTAT is a fully automated immunoanalyser that enables on-site simultaneous detection of up to 44 analytes from a single sample of oral fluid, urine or blood. It requires a small sample volume and generates results in less than 20 minutes. The process from sample entry to results can be completed in 3 simple steps, with minimum room for human error. The process is designed to make set up and analysis as quick, simple and reliable as possible.
The MultiSTAT offers a very simple drug screening solution to those who have no knowledge of laboratory procedures through combining simplicity with cutting-edge innovation. It is this innovative technology that enables the MultiSTAT to be easy to use, yet extremely powerful.
- Fully automated benchtop immunoanalyser
- Up to 132 tests per hour
- Results generated in 17 minutes
- Up to 44 analytes screened per biochip
- 3 steps from sample entry to results
- No laboratory / laboratory experience required to operate
- Suitable for use in a range of laboratory and non-laboratory settings
- 59cm (H) x 54cm (D) x 57cm (W)
Evidence MultiSTAT Test Menu
AB-PINACA | Benzodiazepines II | EtG | Ketamine | TCA |
Amphetamine | Buprenorphine | Fentanyl | LSD | UR-144 / XLR II |
a-PVP | BZG/Cocaine | Methadone | Opiates | JWH-018 |
Barbiturates | Cannabinoids | Methamphetamine | Oxycodone | 6 MAM |
Benzodiazepines I | Dextromethorphan | Creatinine | Tramadol | PCP |
Committed to meeting customers’ needs
At Randox Quality Control, we strive to meet and exceed customer expectations ensuring high quality products and superior customer service are at the top of our priority list.
How can Randox Quality Control help you?
High Quality QC
The Acusera range of true third party controls boasts an impressive range of benefits ultimately designed to help laboratories reduce costs and time while also ensuring an accurate and reliable test system.
The extended shelf life of our controls allows the same lot of control to be used for a period of up to 2 years keeping costly new lot validation studies to a minimum. We may also be able to sequester lots on your behalf.
The availability of commutable controls designed to react to the test system in the same manner as a patient sample and controls targeted at clinical decision levels will not only help you to meet ISO 15189:2012 requirements but will effectively challenge instrument performance.
Click here to find out more about our QC range.
Customer support
The Randox global support network are on hand with expert advice to ensure timely, accurate and helpful resolution of any issues or queries you may have. The added benefit of quick delivery of product orders further highlights how we work with and for our customers to provide the best service available.
Customer Reviews
Don’t believe us? Read a few of the reviews we have received from laboratories around the world;
“I would like to thank the Randox team for the excellent service when helping to reserve and manage our IQC orders, lot numbers and stock.” – Chief Biomedical Scientist, London, 2017.
Request your free QC consultation by contacting us today! Get in touch and we can arrange for your laboratory to have a consultation with one of our Randox QC specialists. Alternatively, if you would like to leave us a review you can do so by emailing acusera@randox.com.
Does Your QC Cover Clinically Relevant Ranges?
Following recommendations from recognized institutions such as ISO and CLIA, more laboratories are using third party controls than ever before. However, great care should be taken when choosing which third party control to use. A number of factors should be considered, and primarily among these is whether the control challenges the complete Clinical Range and the Medical Decision Levels. ISO 15189:2012 states that ‘The laboratory should choose concentrations of control materials wherever possible, especially at or near clinical decision values, which ensure the validity of decisions made’.
Measuring the Complete Clinical Range
It is important to assess the full clinical range of an assay i.e. the range between the lowest and highest results which can be reliably reported. In order to make sure a laboratory instrument is working across the full clinical range, a QC which covers low, normal and elevated concentrations must be used.
Question: “If the full clinical range isn’t covered by QC, how will we know whether patient results which fall outside the range of quality controls are accurately reported?”
What are Medical Decision Levels?
Medical Decision Levels (MDL) are the analyte values at which medical professionals can determine whether a patient may be suffering from a certain condition. The MDL is determined by a consensus of medical professionals and clinical research. Patients’ test results are compared to the MDL and appropriate diagnoses or medical interventions can be made.
For example, the MDL of Glucose can indicate a certain diabetic status:
Analyte | Medical Decision Level | Diagnostic Status |
Glucose (fasting) | <100 mg/dL | Non-Diabetic |
100–125 mg/dL | Pre-Diabetic | |
>125 mg/dL | Diabetic |
Competitor QC
Many QC manufacturers ‘cut corners’ in an attempt to keep costs down, which often results in the sale of controls which do not cover the complete clinical range or vital medical decision levels. Below is an example of the Glucose concentrations present in a competitor control:
Competitor Chemistry Control Level 1 – 68 mg/dL
Competitor Chemistry Control Level 2 – 134 mg/dL
Competitor Chemistry Control Level 3 – 386 mg/dL
In the examples above, the competitor’s level 1 control covers the non-diabetic MDL, but the level 2 control is not within the ‘Pre-Diabetic’ decision range. The level 3 control is also much higher than can be expected for an elevated diabetic patient result (200 mg/dL or more).
Randox QC
Due to the superior manufacturing process used by Randox, QC target values are consistently within the MDL of tests. For example, the Glucose concentrations present in our Liquid Assayed Chemistry Premium Plus control are:
Level 1 – 57 mg/dL
Level 2 – 114 mg/dL
Level 3 – 236 mg/dL
The MDL for Glucose is covered by the Randox control, meaning laboratory professionals can be confident that patient results will be accurately interpreted.
Immunoassay Medical Decision Levels
Controls which cover the MDL can reduce the number of Quality Controls required by laboratories. For example, Randox Acusera Lyophilised Immunoassay Controls contain particularly low levels of TSH, Ferritin and Vitamin B12 in the Level 1 control, eliminating the need for an additional control at extra expense:
Analyte | Medical Decision Level | Randox Level 1 IA Control | Competitor Level 1 IA Control |
TSH | 0.1 or 0.27 uU/mL | 0.15uU/mL | 0.37 uU/mL |
Vitamin B12 | 190 pmol/L | 174 pmol/L | 327 pmol/L |
Ferritin | 12 ng/mL | 11.1 ng/mL | 49.6 ng/mL |
In this example the competitor offers an anaemia control with lower levels of TSH, Vitamin B12 and Ferritin at an additional cost. With Randox Acusera QC, only one control is required for anemia monitoring and detection.
PTH Quality Control
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
Providing a true third party solution for the measurement of Intact PTH, the new Acusera PTH Control will deliver an unbiased,
independent assessment of analytical performance with any instrument or method.
This notoriously unstable marker, present in a number of immunoassay controls, is now available in a liquid frozen format with an impressive 30 day open vial stability, reducing waste while remaining easy-to-use.
Features & Benefits
- Liquid Frozen
- 100% human serum
- Assayed target values available for many immunoassay platforms
- Stable to expiry date at -20°C to 70°C
- Open vial stability of 30 days at 2°C to 8°C
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
PTH Control Level 1 | 3 x 3 ml | 1 | PTH10110 | |
PTH Control Level 2 | 3 x 3 ml | 1 | PTH10111 | |
PTH Control Level 3 | 3 x 3 ml | 1 | PTH10112 | |
Analytes
- Intact PTH (Parathyroid Hormone)
Related Products
Maternal Quality Control
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
The Randox Acusera Maternal quality control is the only commercially available control to cover all six analytes used during first and second trimester screening of Down syndrome and Spina Bifida. Assayed instrument specific target values and ranges are provided for AFP, β hCG, Inhibin A, PAPP-A, Total hCG and Unconjugated Estriol. The inclusion of Inhibin A and PAPP-A eliminates the need to purchase additional controls at extra expense.
Features & Benefits
- Lyophilised for enhanced stability
- 100% human serum
- Assayed target values provided for 6 parameters
- Suitable for double, triple and quad screens
- Unconjugated Estriol present at clinically significant levels
- Stable to expiry date at 2°C – 8°C
- Reconstituted stability of 7 days at 2°C – 8°C
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Maternal Control Level 1 | 3 x 1 ml | 6 | MSS5024 | |
Maternal Control Level 2 | 3 x 1 ml | 6 | MSS5025 | |
Maternal Control Level 3 | 3 x 1 ml | 6 | MSS5026 | |
Analytes
- AFP
- PAPP-A
- Free Beta hCG
- Total hCG
- Inhibin A
- Unconjugated Oestriol
Tumour Marker Quality Control
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
The Randox Acusera Tumour Marker quality control covers 15 cancer antigens and tumour markers making it ideal for even the most demanding laboratories. The inclusion of assayed, instrument specific target values enables effective monitoring of both accuracy and precision.
Features & Benefits
- Lyophilised for enhanced stability
- 100% human serum
- Assayed instrument specific target values provided for 15 parameters
- Stable to expiry date at 2°C – 8°C
- Reconstituted stability of up to 14 days at 2°C – 8°C
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Tumour Marker Control Level 2 | 3 x 2 ml | 15 | TU5002 | |
Tumour Marker Control Level 3 | 3 x 2 ml | 15 | TU5003 | |
Analytes
- AFP
- Beta-2- Microglobulin
- CA 15-3
- CA 19-9
- CA 72-4
- CA 125
- Calcitonin
- CEA
- Cyfra 21-1
- Ferritin
- hCG
- Neuron Specific Enolase (NSE)
- PSA (Free)
- PSA (Total)
- Thyroglobulin
Immunoassay Speciality II Quality Control
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
The Randox Acusera Immunoassay Speciality II quality control is designed to complement our Immunoassay Premium and Premium Plus controls. Assayed, instrument specific target values and ranges are provided for 4 complex immunoassay parameters.
Features & Benefits
- Lyophilised for enhanced stability
- 100% human serum
- Assayed target values provided for 4 parameters
- Stable to expiry date at 2°C – 8°C
- Reconstituted stability of up to 5 days at 2°C – 8°C and 4 weeks at -20°C
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Immunoassay Speciality II Level 1 | 5 x 1ml | 4 | IAS3117 | |
Immunoassay Speciality II Level 2 | 5 x 1ml | 4 | IAS3118 | |
Immunoassay Speciality II Level 3 | 5 x 1ml | 4 | IAS3119 | |
Analytes
- Calcitonin
- Renin
- Gastrin
- Procalcitonin
Immunoassay Speciality I Quality Control
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
![acusera-qc-logo Therapeutic Drug Quality Control](https://www.randox.com/wp-content/uploads/2015/10/acusera-qc-logo-300x44.png)
The Randox Acusera Immunoassay Speciality I quality control is a specialised control designed to complement our Immunoassay Premium and Premium Plus controls. Assayed, instrument specific target values and ranges are provided for 10 complex immunoassay parameters including Procalcitonin, Anti-TG, Anti-TPO and Vitamin D.
Features & Benefits
- Lyophilised for enhanced stability
- 100% human serum
- Assayed target values provided for 10 parameters
- Stable to expiry date at 2°C – 8°C
- Reconstituted stability of up to 5 days at 2°C – 8°C and 4 weeks at -20°C
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Immunoassay Speciality I Level 1 | 5 x 2ml | 10 | IAS3113 | |
Immunoassay Speciality I Level 2 | 5 x 2ml | 10 | IAS3114 | |
Immunoassay Speciality I Level 3 | 5 x 2ml | 10 | IAS3115 | |
Analytes
- 1-25-(OH)2-Vitamin D
- 25-OH-Vitamin D
- C-Peptide
- Insulin
- Insulin Like Growth Factor I
- Osteocalcin*
- Procalcitonin
- Parathyroid Hormone (PTH)
- Anti-Thyroglobulin (Anti-TG)
- Anti-Thyroperoxidase (Anti-TPO)